KyungMann Kim

University of Wisconsin–Madison — United States

Mathematics · Physical Sciences

18h-index2.6kcitations27works1.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Statistical Methods and Bayesian Inference(4), Immune Cell Function and Interaction(4), Neuroblastoma Research and Treatments(4), Lung Cancer Research Studies(4), Lung Cancer Treatments and Mutations(3)

Publications27 total

Effectiveness of electronic medical record-based strategies for death and hospital admission endpoint capture in pragmatic clinical trials
Journal of the American Medical Informatics Association·2024· 3 citedOpen Access
Maintenance low-dose fixed duration lenalidomide and rituximab following bendamustine and rituximab induction in previously untreated chronic lymphocytic leukemia and small lymphocytic lymphoma
Leukemia & lymphoma/Leukemia and lymphoma·2024
Influenza vaccination: a ‘shot’ at INVESTing in cardiovascular health
European Heart Journal·2021· 8 citedOpen Access
Decitabine induction with myeloablative conditioning and allogeneic hematopoietic stem cell transplantation in high-risk patients with myeloid malignancies is associated with a high rate of infectious complications
Leukemia Research·2020· 13 citedOpen Access
Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab
Journal for ImmunoTherapy of Cancer·2019· 23 citedOpen Access
High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trial
American Heart Journal·2018· 43 citedOpen Access
Targeting insulin‐like growth factor 2 mRNA‐binding protein 1 (IGF2BP1) in metastatic melanoma to increase efficacy of BRAF<sup>V600E</sup> inhibitors
Molecular Carcinogenesis·2018· 41 citedOpen Access
HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy
Frontiers in Immunology·2017· 21 citedOpen Access
RNA-Binding Protein IGF2BP1 in Cutaneous Squamous Cell Carcinoma
Journal of Investigative Dermatology·2016· 12 cited
Marginal Mean Models for Zero-Inflated Count Data
Biometrics·2016· 18 citedOpen Access
“Right to Try” laws
Clinical Trials·2014· 10 cited
Phase I Trial of a Novel Anti-GD2 Monoclonal Antibody, Hu14.18K322A, Designed to Decrease Toxicity in Children With Refractory or Recurrent Neuroblastoma
Journal of Clinical Oncology·2014· 158 citedOpen Access
Hydration with Saline Decreases Toxicity of Mice Injected With Calcitriol in Preclinical Studies
Journal of Environmental Pathology Toxicology and Oncology·2013· 2 cited
Intratumoral hu14.18–IL-2 (IC) Induces Local and Systemic Antitumor Effects That Involve Both Activated T and NK Cells As Well As Enhanced IC Retention
The Journal of Immunology·2012· 72 citedOpen Access
On the Efficiency of Score Tests for Homogeneity in Two‐Component Parametric Models for Discrete Data
Biometrics·2012· 18 citedOpen Access
Genotypes of NK Cell KIR Receptors, Their Ligands, and Fcγ Receptors in the Response of Neuroblastoma Patients to Hu14.18-IL2 Immunotherapy
Cancer Research·2010· 173 citedOpen Access
Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells
Molecular Cancer·2010· 117 citedOpen Access
A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC)
Investigational New Drugs·2010· 109 citedOpen Access
Semiparametric regression models and sensitivity analysis of longitudinal data with non‐random dropouts
Statistica Neerlandica·2009· 2 citedOpen Access
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
New England Journal of Medicine·2006· 1.0k citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Jacquelyn A. Hank(6), Paul M. Sondel(6), Jacek Gan(4), Songwon Seo(4), Stephen D. Gillies(4), David Todem(4), Scott D. Solomon(3), Ralph A. Reisfeld(3), Joan H. Schiller(3), Orly Vardeny(3), Jacob A. Udell(3), Jacob Joseph(3), Thomas C. Havighurst(3), Vaishalee P. Kenkre(3), Janet Wittes(2), Sandra J. Horning(2), Richard K. Yang(2), Wendy B. London(2), John M. Maris(2), Mark R. Albertini(2)